Kissei Pharmaceutical Co., Ltd.
_________________________________________________________________________________
Kissei Pharmaceutical Co., Ltd. Financial Snapshot
Operating Performance
Fast Facts
19-48 Yoshino, Matsumoto, 399- The company reported revenue of US$733.16 million
Headquarters Address
8710,Japan during the fiscal year 2011 (2011). The company's
revenue grew at a CAGR of 7.69% during 2007–
Telephone + 81 263 259081
2011, with an annual growth of 3.56% over 2010. In
2011, the company recorded an operating margin of
Fax N/A 8.56%, as against 10.27% in 2010.
Website www.kissei.co.jp
Revenue and Margins
Ticker Symbol, Stock Exchange 4547, The Tokyo Stock Exchange
Number of Employees 1,600
Fiscal Year End March
Revenue (in US$ million) 733.16
Revenue (in JPY million) 64,393.00
SWOT Analysis
Strengths Weaknesses
Focus on research and development Low return on equity
Strong liquidity position Weak operating margin
Opportunities Threats
Changing demographics Increased pricing control
Strategic agreements Industry consolidation
Strong product pipeline Uncertain R&D outcomes
___________________________________________________________________________________________
Kissei Pharmaceutical Co., Ltd. - SWOT Profile Page 1
Kissei Pharmaceutical Co., Ltd.
_________________________________________________________________________________
TABLE OF CONTENTS
1 Business Analysis ................................................................................................................................... 5
1.1 Company Overview ................................................................................................................................................5
1.2 Business Description ..............................................................................................................................................5
1.3 Major Products and Services .................................................................................................................................6
2 Analysis of Key Performance Indicators ............................................................................................... 7
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
2.2 Key Financial Performance Indicators .................................................................................................................10
2.2.1 Revenue and Operating Profit .........................................................................................................................10
2.2.2 Asset, Liabilities and Capex .............................................................................................................................11
2.2.3 Operational Efficiency ......................................................................................................................................12
2.2.4 Solvency ..........................................................................................................................................................13
2.2.5 Valuation ..........................................................................................................................................................14
2.3 Key Competitors ...................................................................................................................................................15
3 Mergers & Acquisitions and Partnerships ........................................................................................... 16
3.1 M&A and Partnerships Strategy ...........................................................................................................................16
4 SWOT Analysis ...................................................................................................................................... 18
4.1 SWOT Analysis - Overview ..................................................................................................................................18
4.2 Strengths ..............................................................................................................................................................18
4.3 Weaknesses .........................................................................................................................................................18
4.4 Opportunities ........................................................................................................................................................19
4.5 Threats .................................................................................................................................................................19
5 Company Statement .............................................................................................................................. 21
6 History .................................................................................................................................................... 23
7 Key Employees ...................................................................................................................................... 25
8 Locations and Subsidiaries .................................................................................................................. 26
8.1 Head Office ..........................................................................................................................................................26
8.2 Other Locations and Subsidiaries ........................................................................................................................26
9 Appendix ................................................................................................................................................ 27
9.1 Methodology .........................................................................................................................................................27
9.2 Ratio Definitions ...................................................................................................................................................27
9.3 Disclaimer.............................................................................................................................................................31
___________________________________________________________________________________________
Kissei Pharmaceutical Co., Ltd. - SWOT Profile Page 2
Kissei Pharmaceutical Co., Ltd.
__________________________________________________________________________________________
List of Tables
Table 1: Major Products and Services....................................................................................................................................6
Table 2: Key Ratios - Annual ..................................................................................................................................................7
Table 3: Key Ratios - Interim ..................................................................................................................................................9
Table 4: Key Capital Market Indicators ...................................................